28 results
8-K
EX-99.1
BTTX
Better Therapeutics Inc
4 Mar 24
Regulation FD Disclosure
8:51am
, as a society, we’ve spent billions of dollars on developing drugs that lower blood sugar, lower blood pressure, cholesterol, and so on. But we spend very
424B3
BTTX
Better Therapeutics Inc
28 Dec 23
Prospectus supplement
9:23pm
in the Journal of the Endocrine Society. In our single-arm pilot study, the addition of the BT-001 treatment regimen to subjects who were, on average, already … research has been highlighted at several conferences including the American College of Lifestyle Medicine, IPSOR 2019, Endocrine 2020, the Society
8-K
EX-99.1
97jyqel39rlr4
12 Jul 23
Better Therapeutics Receives FDA Authorization for AspyreRxTM to Treat Adults with Type 2 Diabetes
12:00am
8-K
EX-99.1
qsxv mpg7cp7zj2
14 Nov 22
Better Therapeutics Reports Third Quarter 2022 Financial Results and Provides
4:10pm
424B3
tmt3jxi c02q
7 Apr 22
Prospectus supplement
4:08pm
POS AM
kmi8b45 3dhier6
1 Apr 22
Prospectus update (post-effective amendment)
4:25pm
424B3
8drnx6w9vt2ib9f
10 Dec 21
Prospectus supplement
6:06am
8-K
EX-99.1
j5f2q za8nck69c5
18 Nov 21
Primary endpoint data expected in Q1 2022
8:31am
425
od2fdwglqbmmiq
20 Oct 21
Business combination disclosure
12:00am
424B3
v5o4c kqhtule
12 Oct 21
Prospectus supplement
5:13pm